deuterium has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Iwasaki, Y; Nakabeppu, Y; Noda, M; Uemura, Y; Yada, T; Yoshii, Y | 1 |
| Castagnoli, N; Flores, J; Isin, EM; Suleman, NK; Tanko, JM | 1 |
| Cantor, CR; Chou, VP; Langston, JW; Manning-Boğ, AB; Molinari, RJ; Pollock, E; Shchepinov, MS | 1 |
3 other study(ies) available for deuterium and Parkinsonian Disorders
| Article | Year |
|---|---|
Complexity of Stomach-Brain Interaction Induced by Molecular Hydrogen in Parkinson's Disease Model Mice.
Topics: Animals; Brain; Deuterium; Gastric Mucosa; Ghrelin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Parkinsonian Disorders; Stomach; Vagotomy; Vagus Nerve | 2017 |
The tert-butoxyl radical mediated hydrogen atom transfer reactions of the Parkinsonian proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and selected tertiary amines.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amines; Carbon; Catalysis; Deuterium; Humans; Hydrogen; Kinetics; Monoamine Oxidase; Neurotoxins; Oxidation-Reduction; Parkinsonian Disorders; Structure-Activity Relationship; tert-Butylhydroperoxide | 2008 |
Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; alpha-Linolenic Acid; Animals; Cell Death; Corpus Striatum; Deuterium; Disease Models, Animal; Fatty Acids, Unsaturated; Linoleic Acid; Mice; Mice, Inbred C57BL; Nerve Degeneration; Oleic Acid; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra | 2011 |